Results 161 to 170 of about 1,327 (186)

Rimegepant

pharma-kritik
N ...
openaire   +1 more source

Oral Rimegepant Safe, Effective for Migraine Prevention

JAMA, 2021
openaire   +2 more sources

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2021
Peter Goadsby, Richard B Lipton
exaly  

Rimegepant

2022
openaire   +1 more source

A real-world adverse events study of rimegepant from the FAERS database

Expert Opinion on Drug Safety
The primary objective of this research is to conduct an exhaustive evaluation of rimegepant with the Food and Drug Administration Adverse Event Reporting System (FAERS) repository.This study downloaded the reporting files related to rimegepant from the second quarter of 2020 to the first quarter of 2024.
Hong Pan, Shasha Lin
openaire   +2 more sources

Nieuw geneesmiddel: rimegepant bij migraineaanvallen

Ge-Bu, 2022
openaire   +1 more source

NICE recommends rimegepant for treating acute migraine in adults

BMJ, 2023
openaire   +2 more sources

New drug: rimegepant for migraine attacks

Ge-Bu, 2022
openaire   +1 more source

Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials

Cephalalgia, 2023
Richard B Lipton, Peter Goadsby
exaly  

Oraler CGRP-Rezeptorantagonist Rimegepant lindert Kopfschmerz und Begleitsymptome

Schmerzmedizin, 2021
openaire   +1 more source